Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE

被引：0
|
作者：
Petar Suton
Marko Skelin
Zoran Rakusic
Stjepan Dokuzovic
Ivica Luksic
机构：
[1] University Hospital for Tumors,Department of Radiotherapy and Medical Oncology
[2] University Hospital Centre “Sisters of Mercy”,Pharmacy Department
[3] General Hospital Sibenik,Department of Oncology
[4] University of Zagreb School of Medicine,Department of Traumatology and Orthopaedics
[5] University Hospital Centre Zagreb,Department of Maxillofacial Surgery
[6] University Hospital Dubrava,undefined
[7] University of Zagreb School of Medicine,undefined
[8] University Hospital Dubrava,undefined
来源：
European Archives of Oto-Rhino-Laryngology | 2019年 / 276卷
关键词：
Oropharyngeal cancer; Human papilloma virus; Cisplatin; Cetuximab; Survival; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1275 / 1281
页数：6
相关论文
共 15 条
  • [1] Cisplatin-based chemoradiotherapy vs. cetuximab-based bioradiotherapy for p16-positive oropharyngeal cancer: an updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Suton, Petar
    Skelin, Marko
    Rakusic, Zoran
    Dokuzovic, Stjepan
    Luksic, Ivica
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (05) : 1275 - 1281
  • [2] Concurrent cisplatin-based chemoradiotherapy versus cetuximab-based bioradiotherapy for p16-positive, locally advanced oropharyngeal cancer: A meta-analysis
    Suton, P.
    Skelin, M.
    Luksic, I.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [3] Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers
    Monali Swain
    Tejpal Gupta
    Sadhana Kannan
    JaiPrakash Agarwal
    [J]. European Archives of Oto-Rhino-Laryngology, 2019, 276 : 2111 - 2112
  • [4] Cisplatin-based chemoradiotherapy trumps cetuximab-based bioradiotherapy in p16/HPV-positive oropharyngeal cancers
    Swain, Monali
    Gupta, Tejpal
    Kannan, Sadhana
    Agarwal, JaiPrakash
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (07) : 2111 - 2112
  • [5] Comparison of high-dose Cisplatin-based chemoradiotherapy and Cetuximab-based bioradiotherapy for p16-positive oropharyngeal squamous cell carcinoma in the context of revised HPV-based staging
    Bhattasali, Onita
    Thompson, Lester D. R.
    Abdalla, Iman A.
    Chen, Jergin
    Iganej, Shawn
    [J]. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2018, 23 (05) : 451 - 457
  • [6] In HPV-associated Oropharyngeal Cancer, Cisplatin-based Chemoradiotherapy is superior to Cetuximab-based Bioradiotherapy in Terms of Overall Survival
    Semrau, Sabine
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (05) : 447 - 449
  • [7] In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Petar Suton
    Marko Skelin
    Zoran Rakusic
    Stjepan Dokuzovic
    Ivica Luksic
    [J]. European Archives of Oto-Rhino-Laryngology, 2019, 276 : 2113 - 2114
  • [8] In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De-ESCALaTE
    Suton, Petar
    Skelin, Marko
    Rakusic, Zoran
    Dokuzovic, Stjepan
    Luksic, Ivica
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (07) : 2113 - 2114
  • [9] Concurrent Cetuximab-based bioradiotherapy versus Cisplatin-based Chemoradiotherapy in the Definitive Management of Favourable Biology Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma: Systematic Review and Meta-analysis
    Swain, M.
    Kannan, S.
    Srinivasan, S.
    Agarwal, J. P.
    Gupta, T.
    [J]. CLINICAL ONCOLOGY, 2022, 34 (12) : 786 - 795
  • [10] Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma An updated meta-analysis based on randomized controlled trials
    Zhu, Jiahao
    Zhang, Zheng
    Bian, Dongyan
    Chen, Qingqing
    Hu, Qunchao
    Ji, Shengjun
    Gu, Ke
    [J]. MEDICINE, 2020, 99 (01)
12